So far, research focusing on NT-3 and NT-4 has focused on improving the understanding of these NTs and the possibility of their therapeutic use in demyelinating and neurodegenerative diseases, depression, and mood disorders [38]. The gene discussed is NTF3; the disease is depressive symptom measurement.